Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 2008, p. 3463-3464, Vol. 52, No. 9
0066-4804/08/$08.00+0 doi:10.1128/AAC.00543-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium

LETTER
Emergence and dissemination of
Enterobacteriaceae isolates harboring
carbapenemases represent a significant threat to the management
of nosocomial infections (
6). Carbapenem-hydrolyzing β-lactamases
can be metallo-β-lactamases, Ambler class A enzymes, or
more rarely expanded-spectrum oxacillinases (
6,
10). The Ambler
class D OXA-48 β-lactamase has been found only in enterobacterial
species (one
Escherichia coli isolate and four
Klebsiella pneumoniae isolates) from Turkey (
1,
5,
9). Here we describe a
K. pneumoniae isolate from Belgium with reduced susceptibility to carbapenems
that produced the β-lactamase OXA-48.
On 27 November 2007, a 37-year-old man undergoing chemotherapy treatment for a lymphoma was hospitalized in the hematology ward of the hospital of St-Luc, Brussels, Belgium, for confusion due to herpetic encephalitis caused by herpes simplex virus type 2. On 29 November, a K. pneumoniae UCL-1 isolate from urine samples was found to be resistant to amoxicillin (AMX) and amoxicillin-clavulanate (AMC) but remained susceptible to expanded-spectrum cephalosporins and to meropenem (MIC of <1 µg/ml) as determined by the Phoenix Microbiology system (Becton-Dickinson, Erembodegem, Belgium) and Vitek (bioMérieux, Marcy l'Etoile, France). As routinely performed for AMX/AMC-resistant isolates, a disk diffusion antibiogram revealed a reduced susceptibility to meropenem (23 mm) and imipenem (22 mm) but intermediate susceptibility to ertapenem (18 mm) (3). In addition, the isolate was also resistant to fluoroquinolones, cotrimoxazole, kanamycin, and tetracycline according to disk diffusion susceptibility testing results. The patient was not treated for its infection and did not develop a systemic infection with K. pneumoniae UCL-1 requiring antibiotic treatment. No other K. pneumoniae isolate with a similar antibiotic resistance pattern was recovered from the hospital during this same period of time.
The MICs of β-lactams determined by the Etest method (AB BIODISK, Solna, Sweden) and interpreted according to CLSI criteria (3) for K. pneumoniae UCL-1 showed MICs of penicillins not modified after addition of clavulanic acid, of imipenem and meropenem in the susceptibility range, and of ertapenem in the intermediate range (Table 1). A crude β-lactamase extract of that isolate showed significant carbapenem-hydrolyzing activity as measured spectrophotometrically (1.6, 0.05, and 0.04 µmol of imipenem, meropenem, and ertapenem, respectively/min/mg of total protein) (4).
View this table:
[in this window]
[in a new window]
|
TABLE 1. MICs of β-lactams for K. pneumoniae 11978, K. pneumoniae UCL-1, their E. coli transconjugants, and E. coli recipient strain J53
|
PCR experiments with primers for detection of Ambler class A,
class D, and class B β-lactamase genes (
4), followed by
sequencing, identified the carbapenemase
blaOXA-48 gene. Using
a series of PCR primers, two IS
1999 elements were found surrounding
the
blaOXA-48 gene in a similar manner to that found in the
prototype
K. pneumoniae 11978 strain from Turkey (
2,
8). Plasmid
analysis detected a 70-kb self-conjugative plasmid of similar
size to pA-1 (OXA-48) in
K. pneumoniae strain 11978 (
9). This
plasmid conferred a β-lactam resistance pattern for
E. coli transconjugants with reduced carbapenem susceptibility
(Table
1). A β-lactamase extract from a transconjugant
culture subjected to analytical isoelectric focusing (
7) identified
one β-lactamase with an isoelectric point of 7.2.
Up to now, carbapenemases of the OXA-48 type have seemed to be limited to Turkey (1, 5, 9). This is the first evidence of the type's identification outside of Turkey for a patient with no apparent relation with this country. Moreover, the fact that reduced susceptibility to carbapenem was not detected by automated systems (Phoenix and Vitek) may suggest that this novel resistance determinant could be more prevalent than expected.
Reduced susceptibility to imipenem and meropenem but with the MIC still in the susceptible range was also observed using Etest. It is likely that resistance may occur only if additional mutations are present beyond OXA-48 or if the plasmid carrying OXA-48 is transferred to bacteria with already-reduced susceptibility to carbapenems. A similar low level of resistance to carbapenems may be observed for KPC and VIM-IMP producers, potentially leading to detection failures (4, 11). Ertapenem seems to be more affected by these enzymes in Enterobacteriaceae and therefore is a better indicator for their detection.

ACKNOWLEDGMENTS
We are grateful to Amélie Carrer for technical assistance.
This work was funded by a grant from the Ministère de l'Education Nationale et de la Recherche (UPRES-EA3539), Université Paris Sud, and by the European Community (6th PCRD, LSHM-CT-2005-018705).

FOOTNOTES

Published ahead of print on 21 July 2008.


REFERENCES
1 - Aktaçs, Z., C. B. Kayacan, I. Schneider, B. Can, K. Midilli, and A. Bauernfeind. 2008. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy 54:101-106.[CrossRef][Medline]
2 - Aubert, D., T. Naas, C. Héritier, L. Poirel, and P. Nordmann. 2006. Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of β-lactam resistance genes. J. Bacteriol. 188:6506-6514.[Abstract/Free Full Text]
3 - Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
4 - Cuzon, G., T. Naas, M. C. Demachy, and P. Nordmann. 2008. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from Greece. Antimicrob. Agents Chemother. 52:796-797.[Free Full Text]
5 - Gülmez, D., N. Woodford, M. F. Palepou, S. Mushtaq, G. Metan, Y. Yakupogullari, S. Kocagoz, O. Uzun, G. Hascelik, and D. M. Livermore. 2008. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int. J. Antimicrob. Agents. 31:523-526.[CrossRef][Medline]
6 - Livermore, D. M., and N. Woodford. 2006. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14:413-420.[CrossRef][Medline]
7 - Naas, T., G. Cuzon, M. V. Villegas, M. F. Lartigue, J. P. Quinn, and P. Nordmann. 2008. Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene. Antimicrob. Agents Chemother. 52:1257-1263.[Abstract/Free Full Text]
8 - Poirel, L., C. Héritier, and P. Nordmann. 2004. Chromosome-encoded ambler class D β-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob. Agents Chemother. 48:348-351.[Abstract/Free Full Text]
9 - Poirel, L., C. Héritier, V. Tolun, and P. Nordmann. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15-22.[Abstract/Free Full Text]
10 - Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458.[Abstract/Free Full Text]
11 - Tato, M., T. M. Coque, P. Ruíz-Garbajosa, V. Pintado, J. Cobo, H. S. Sader, R. N. Jones, F. Baquero, and R. Cantón. 2007. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin. Infect. Dis. 45:1171-1178.[CrossRef][Medline]
| | | | | |
Gaelle Cuzon
Thierry Naas*
Service de Bactériologie-Virologie Hôpital de Bicêtre Assistance Publique-Hôpitaux de Paris Faculté de Médecine Paris-Sud 94275 Le Kremlin-Bicêtre, France
Pierre Bogaerts
Youri Glupczynski
Laboratoire de Bactériologie Université Catholique de Louvain UCL-Mont-Godinne Yvoir, Belgium
Te-Din Huang
Laboratoire de Bactériologie Université Catholique de Louvain UCL-Saint Luc Brussels, Belgium
Patrice Nordmann
INSERM U914: Emerging Resistance to Antibiotics Hôpital de Bicêtre Assistance Publique-Hôpitaux de Paris Faculté de Médecine Université Paris-Sud 94275 Le Kremlin-Bicêtre, France
|
| | | | | |
* Phone: 33-1-45-21-20-19 Fax: 33-1-45-21-63-40 E-mail: thierry.naas{at}bct.ap-hop-paris.fr |
Antimicrobial Agents and Chemotherapy, September 2008, p. 3463-3464, Vol. 52, No. 9
0066-4804/08/$08.00+0 doi:10.1128/AAC.00543-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.